Earnings calendar/ALLO
Allogene Therapeutics, Inc. (ALLO)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.13
Street estimate
Revenue target
$2,222
Street estimate
Trailing EPS (avg 4Q)
$-0.17
Beat rate last 4: 100%
Latest EPS YoY
+43.5%
vs 2025-08-13
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$4.6M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 12, 2026
EPS beat
EPS actual / est
$-0.13 / $-0.17
+24.2%
Revenue actual / est
$4.6M / $2,500
+185500.0%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.13 | Pending | — | $2,222 | Pending | — |
| 8/12/2026 | $-0.17 | $-0.13 | +24.2% | $2,500 | $4.6M | +185500.0% |
| 5/13/2026 | $-0.19 | $-0.18 | +5.3% | $2,222 | Pending | — |
| 5/12/2026upcoming | $-0.19 | Pending | — | $2,222 | Pending | — |
| 3/12/2026 | $-0.25 | $-0.17 | +32.0% | $2,500 | Pending | — |
| 11/6/2025 | $-0.23 | $-0.19 | +17.4% | $1,820 | Pending | — |
| 8/13/2025 | $-0.28 | $-0.23 | +17.9% | — | Pending | — |
| 5/13/2025 | $-0.28 | $-0.28 | 0.0% | $1,670 | Pending | — |
| 3/13/2025 | $-0.34 | $-0.28 | +17.6% | $12,000 | $22,000 | +83.3% |
| 11/7/2024 | $-0.34 | $-0.27 | +20.6% | $12,110 | Pending | — |
| 8/7/2024 | $-0.35 | $-0.32 | +8.6% | $20,000 | Pending | — |
| 5/13/2024 | $-0.38 | $-0.38 | 0.0% | $10,000 | $22,000 | +120.0% |
| 3/14/2024 | $-0.47 | $-0.43 | +8.5% | $20,000 | $21,000 | +5.0% |
| 11/2/2023 | $-0.53 | $-0.37 | +30.2% | $20,000 | $43,000 | +115.0% |
| 8/2/2023 | $-0.59 | $-0.53 | +10.2% | $20,000 | $44,000 | +120.0% |
| 5/3/2023 | $-0.63 | $-0.68 | -7.9% | $10,000 | $52,000 | +420.0% |
| 2/28/2023 | $-0.71 | $-0.66 | +7.0% | $77,182 | $47,000 | -39.1% |
| 11/2/2022 | $-0.62 | $-0.58 | +6.5% | $7,167 | $49,000 | +583.7% |
| 8/9/2022 | $-0.61 | $-0.52 | +14.8% | $12,385 | $86,000 | +594.4% |
| 5/4/2022 | $-0.59 | $-0.56 | +5.1% | $8,333 | $61,000 | +632.0% |
| 2/23/2022 | $-0.61 | $-0.54 | +11.5% | $56,099 | $51,000 | -9.1% |
| 11/4/2021 | $-0.56 | $-0.57 | -1.8% | $10,000 | $49,000 | +390.0% |
| 8/4/2021 | $-0.55 | $-0.53 | +3.6% | $230,000 | $44,000 | -80.9% |
| 5/5/2021 | $-0.48 | $-0.25 | +47.9% | $12.8M | $38.3M | +198.6% |
| 2/25/2021 | $-0.56 | $-0.53 | +5.4% | $2.7M | Pending | — |
| 11/4/2020 | $-0.55 | $-0.52 | +5.5% | — | Pending | — |
| 8/5/2020 | $-0.55 | $-0.53 | +3.6% | $224,150.94 | Pending | — |
| 5/6/2020 | $-0.57 | $-0.50 | +12.3% | — | Pending | — |
| 2/27/2020 | $-0.69 | $-0.58 | +15.9% | — | Pending | — |
| 11/5/2019 | $-0.54 | $-0.50 | +7.4% | — | Pending | — |
| 8/7/2019 | $-0.47 | $-0.41 | +12.8% | — | Pending | — |
| 5/7/2019 | $-0.41 | $-0.32 | +22.0% | — | Pending | — |
| 3/8/2019 | $-0.23 | $-0.35 | -52.2% | — | Pending | — |
| 11/22/2018 | $-0.30 | $-10.71 | -3470.0% | — | Pending | — |
| 10/11/2018 | — | $-1.19 | — | — | Pending | — |
| 3/31/2018 | — | $-0.06 | — | — | Pending | — |